Could protein biologics be a pioneering approach in ophthalmology?

The latest episode of the DDW 'In Conversation With' series is available to listen to below. This week, Bruno Quinney speaks to Reuben Dawkins, CEO of Link Biologics, a company developing protein biologics to treat inflammatory and degenerative conditions. Link is currently developing treatments for Dry Eye Disease and Wet AMD. Bruno chats to Reuben about why Link chose to target Dry Eye Disease with its pioneering approach, how the company saw an opportunity to compete with current treatments for Wet AMD, and whether the science behind Link's protein biologics could be used beyond ophthalmology. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.